MedPath
HSA Approval

CAVSAMIR FILM COATED TABLET 800MG

SIN16993P

CAVSAMIR FILM COATED TABLET 800MG

CAVSAMIR FILM COATED TABLET 800MG

April 26, 2024

EURO ASIA MEDICO PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantEURO ASIA MEDICO PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

V03AE02

Manufacturer Information

EURO ASIA MEDICO PTE. LTD.

Dr. Reddy's Laboratories Limited

Active Ingredients

Sevelamer Carbonate

800 mg

Sevelamer

Documents

Package Inserts

CAVSAMIR Tablet PI.pdf

Approved: April 26, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CAVSAMIR FILM COATED TABLET 800MG - HSA Approval | MedPath